These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30905444)

  • 1. Glycan-based biomarkers for diagnosis of cancers and other diseases: Past, present, and future.
    Hu M; Lan Y; Lu A; Ma X; Zhang L
    Prog Mol Biol Transl Sci; 2019; 162():1-24. PubMed ID: 30905444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycoproteins in the Sera of Oncological Patients.
    Hernychová L; Uhrík L; Nenutil R; Novotný MV
    Klin Onkol; 2019; 32(Supplementum 3):39-45. PubMed ID: 31627705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sensitivity and specificity of serum glycan-based biomarkers for cancer detection.
    Tang Y; Cui Y; Zhang S; Zhang L
    Prog Mol Biol Transl Sci; 2019; 162():121-140. PubMed ID: 30905445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isomer-specific profiling of N-glycans derived from human serum for potential biomarker discovery in pancreatic cancer.
    Liu Y; Wang C; Wang R; Wu Y; Zhang L; Liu BF; Cheng L; Liu X
    J Proteomics; 2018 Jun; 181():160-169. PubMed ID: 29674015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycans as cancer biomarkers.
    Adamczyk B; Tharmalingam T; Rudd PM
    Biochim Biophys Acta; 2012 Sep; 1820(9):1347-53. PubMed ID: 22178561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rapid mass spectrometric strategy for the characterization of N- and O-glycan chains in the diagnosis of defects in glycan biosynthesis.
    Faid V; Chirat F; Seta N; Foulquier F; Morelle W
    Proteomics; 2007 Jun; 7(11):1800-13. PubMed ID: 17520685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum glycoprotein-derived N- and O-linked glycans as cancer biomarkers.
    Lan Y; Hao C; Zeng X; He Y; Zeng P; Guo Z; Zhang L
    Am J Cancer Res; 2016; 6(11):2390-2415. PubMed ID: 27904760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative O-glycomics based on improvement of the one-pot method for nonreductive O-glycan release and simultaneous stable isotope labeling with 1-(d
    Wang C; Zhang P; Jin W; Li L; Qiang S; Zhang Y; Huang L; Wang Z
    J Proteomics; 2017 Jan; 150():18-30. PubMed ID: 27585995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation.
    Arnold JN; Saldova R; Hamid UM; Rudd PM
    Proteomics; 2008 Aug; 8(16):3284-93. PubMed ID: 18646009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies against aberrant glycans as cancer biomarkers.
    Blsakova A; Kveton F; Kasak P; Tkac J
    Expert Rev Mol Diagn; 2019 Dec; 19(12):1057-1068. PubMed ID: 31665948
    [No Abstract]   [Full Text] [Related]  

  • 11. Retrospective analysis of glycan-related biomarkers based on clinical laboratory data in two medical centers during the past 6 years.
    Zhang M; Dou H; Yang D; Shan M; Li X; Hao C; Zhang Y; Zeng P; He Y; Liu Y; Fu J; Wang W; Hu M; Li H; Tian Q; Lei S; Zhang L
    Prog Mol Biol Transl Sci; 2019; 162():141-163. PubMed ID: 30905446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of serum N-glycan profiling as a diagnostic and prognostic biomarker in germ-cell tumors.
    Narita T; Hatakeyama S; Yoneyama T; Narita S; Yamashita S; Mitsuzuka K; Sakurai T; Kawamura S; Tochigi T; Takahashi I; Nakaji S; Tobisawa Y; Yamamoto H; Koie T; Tsuchiya N; Habuchi T; Arai Y; Ohyama C
    Cancer Med; 2017 Apr; 6(4):739-748. PubMed ID: 28317343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum glycome profiling: a biomarker for diagnosis of ovarian cancer.
    Biskup K; Braicu EI; Sehouli J; Fotopoulou C; Tauber R; Berger M; Blanchard V
    J Proteome Res; 2013 Sep; 12(9):4056-63. PubMed ID: 23889230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of 34 N-glycan isomers in human serum by capillary electrophoresis coupled with laser-induced fluorescence allows improving glycan biomarker discovery.
    Schwedler C; Kaup M; Weiz S; Hoppe M; Braicu EI; Sehouli J; Hoppe B; Tauber R; Berger M; Blanchard V
    Anal Bioanal Chem; 2014 Nov; 406(28):7185-93. PubMed ID: 25234305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-glycan signatures identified in tumor interstitial fluid and serum of breast cancer patients: association with tumor biology and clinical outcome.
    Terkelsen T; Haakensen VD; Saldova R; Gromov P; Hansen MK; Stöckmann H; Lingjaerde OC; Børresen-Dale AL; Papaleo E; Helland Å; Rudd PM; Gromova I
    Mol Oncol; 2018 Jun; 12(6):972-990. PubMed ID: 29698574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fucosylated Glycans in α1-Acid Glycoprotein for Monitoring Treatment Outcomes and Prognosis of Cancer Patients.
    Yazawa S; Takahashi R; Yokobori T; Sano R; Mogi A; Saniabadi AR; Kuwano H; Asao T
    PLoS One; 2016; 11(6):e0156277. PubMed ID: 27295180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics.
    Taniguchi N; Kizuka Y
    Adv Cancer Res; 2015; 126():11-51. PubMed ID: 25727145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression.
    Abd Hamid UM; Royle L; Saldova R; Radcliffe CM; Harvey DJ; Storr SJ; Pardo M; Antrobus R; Chapman CJ; Zitzmann N; Robertson JF; Dwek RA; Rudd PM
    Glycobiology; 2008 Dec; 18(12):1105-18. PubMed ID: 18818422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative Quantification and Higher-Order Modeling of the Plasma Glycan Cancer Burden Ratio in Ovarian Cancer Case-Control Samples.
    Hecht ES; Scholl EH; Walker SH; Taylor AD; Cliby WA; Motsinger-Reif AA; Muddiman DC
    J Proteome Res; 2015 Oct; 14(10):4394-401. PubMed ID: 26347193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles.
    Kyselova Z; Mechref Y; Kang P; Goetz JA; Dobrolecki LE; Sledge GW; Schnaper L; Hickey RJ; Malkas LH; Novotny MV
    Clin Chem; 2008 Jul; 54(7):1166-75. PubMed ID: 18487288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.